CD4 + T counts with a course of antituberculous therapy in healthy and HIV-infected patients.
A prospective study of CD4 + T lymphocytes with a course of treatment on 20 HIV-infected patients with active tuberculosis receiving antituberculous drugs was compared with 30 non HIV-infected patients with active tuberculosis. The CD4 + T cell counts among non HIV-infected patients were 510 +/- 409 and increased to 634 +/- 382 and 867 +/- 248 at the third and sixth month of therapy. Among HIV-infected patients, the CD4 + T cell counts were 64 +/- 42 and decreased to 40 +/- 23 and 35 +/- 16 in the third and sixth month of therapy (p < 0.05).
Saenghirunvattana
S
S
Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000276:immunology*; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D005260:Female; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013601:T-Lymphocytes / Q000276:immunology*; D014376:Tuberculosis / Q000188:drug therapy / Q000276:immunology*
D000995:Antitubercular Agents